Trademark: 88942264
Status Date
Monday, January 8, 2024
Filing Date
Monday, June 1, 2020
Published for Opposition
Tuesday, October 13, 2020
Abandoned Date
Monday, January 8, 2024
5 Pharmaceutical preparations and substances, namely, polypeptides, antibodies, and antibody derivatives, for use in the treatment of autoimmune disorders and conditions, and cancer
1 Therapeutic protein molecules used in the manufacture of pharmaceuticals and biologically-derived medical preparations
Jan 8, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 8, 2024
Abandonment - No Use Statement Filed
Jun 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 13, 2023
Sou Extension 5 Granted
Jun 6, 2023
Sou Extension 5 Filed
Jun 13, 2023
Case Assigned To Intent To Use Paralegal
Jun 6, 2023
Sou Teas Extension Received
Dec 10, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 8, 2022
Sou Extension 4 Granted
Dec 8, 2022
Sou Extension 4 Filed
Dec 8, 2022
Sou Teas Extension Received
Jun 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 7, 2022
Sou Extension 3 Granted
Jun 7, 2022
Sou Extension 3 Filed
Jun 7, 2022
Sou Teas Extension Received
Dec 9, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 7, 2021
Sou Extension 2 Granted
Dec 7, 2021
Sou Extension 2 Filed
Dec 7, 2021
Sou Teas Extension Received
Jun 4, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 2, 2021
Sou Extension 1 Granted
Jun 2, 2021
Sou Extension 1 Filed
Jun 2, 2021
Sou Teas Extension Received
Dec 8, 2020
Noa E-Mailed - Sou Required From Applicant
Oct 13, 2020
Official Gazette Publication Confirmation E-Mailed
Oct 13, 2020
Published For Opposition
Sep 23, 2020
Notification Of Notice Of Publication E-Mailed
Sep 3, 2020
Approved For Pub - Principal Register
Sep 2, 2020
Assigned To Examiner
Jun 22, 2020
New Application Office Supplied Data Entered
Jun 4, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
